Menu

ImmunityBio, Inc. IBRX

Full chart Compare
Set alert

Price alert · IBRX

All alert types
6.23 USD -0.45 (-6.67%)

Nov 12, 2026, 12:43 PM EST

6.10 Day range 6.50
1.95 52-week range 12.43
YTD
+214.39%
1 year
+202.18%

Discussion (3506)

Sign in to join the discussion

frank fager IBRX 5 months ago #1091

The beauty of Anktiva it can and could be used with all cancer therapies including chemo and radiation

frank fager IBRX 5 months ago #1092

I say it all the time. If if we would get honest media coverage like on CBS NBC PBS MSNBC Fox FoxB or CNBC we would already be $25-$50

frank fager IBRX 5 months ago #1093

Let's go IBRX up everyday .5-.75 everyday up up up.

frank fager IBRX 5 months ago #1094

Only the evil hedge fund Wall Street criminals would short a company with this much potential. Only evil POS attorneys would litigate a company like ImmunityBio.
The 2 work together trying to slow or destroy ImmunityBio to protect big pharma and corporate "healthcare" from a true disrupter. The world is run by greedy evil people.

frank fager IBRX 5 months ago #1096

Nice up day and was up all day ALL DAY...

Need several more and a couple weeks and maybe close at $12.50

frank fager IBRX 5 months ago #1097

I see IBRX rising about $1 every 1-2 weeks all the way to $15 over the next 3-4 months

We proper MSM coverage instead of ImmunityBio getting a blackout in the coverage $15-$20 fast

frank fager IBRX 5 months ago #1098

My father had a Gleoblastoma and it killed him in less than 6 months 2005 when the symptoms started it was already the size of a tennis ball.

frank fager IBRX 5 months ago #1099

Let's do some math for ImmunityBio IBRX
Market cap

Current 8.2 billion stock prices is $7.80

30 billion stock price would be about $30

50 billion $50

75 billion $75

100 billion $100

1 trillion $1000

Who knows, I bet at least 300 billion same as Merck someday. So $300/share

frank fager IBRX 5 months ago #1100

Well was hoping for more of a bounce why? It feels good but I tell myself what matters is sales sales growth and additional use approvals. That's all coming over the next several years. So where will we be in 2-5 years? $50-$300 a share is my bet